Cargando…

Upregulation of microRNA-122 by farnesoid X receptor suppresses the growth of hepatocellular carcinoma cells

BACKGROUND: microRNA-122 (miR-122) is the most abundant and specific miRNA in the liver. It acts as an important tumor suppressor in hepatocellular carcinoma (HCC) through regulating its target genes, but details of its own regulation are largely unknown. Farnesoid X receptor (FXR), a transcription...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Jialin, Zhao, Kai, Zheng, Lu, Xu, Zhizhen, Gong, Wei, Chen, Shan, Shen, Xiaodong, Huang, Gang, Gao, Min, Zeng, Yijun, Zhang, Yan, He, Fengtian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4547435/ https://www.ncbi.nlm.nih.gov/pubmed/26302777 http://dx.doi.org/10.1186/s12943-015-0427-9

Ejemplares similares

FXR induces SOCS3 and suppresses hepatocellular carcinoma
por: Guo, Fei, et al.
Publicado: (2015)

Bioinformatics analysis of gene expression alterations in microRNA-122 knockout mice with hepatocellular carcinoma
por: He, Bosheng, et al.
Publicado: (2017)

Upregulation of microRNA-23b-3p induced by farnesoid X receptor regulates the proliferation and apoptosis of osteosarcoma cells
por: Wu, Bin, et al.
Publicado: (2019)

HIV Vpr protein upregulates microRNA-122 expression and stimulates hepatitis C virus replication
por: Peng, Milin, et al.
Publicado: (2015)

Activation of FXR protects against renal fibrosis via suppressing Smad3 expression
por: Zhao, Kai, et al.
Publicado: (2016)

Induction of SOCS3 by liver X receptor suppresses the proliferation of hepatocellular carcinoma cells
por: Xiong, Haojun, et al.
Publicado: (2017)

Molecular Targets and Signaling Pathways of microRNA-122 in Hepatocellular Carcinoma
por: Chun, Kwang-Hoon
Publicado: (2022)

Upregulation of miR-124-3p by Liver X Receptor Inhibits the Growth of Hepatocellular Carcinoma Cells Via Suppressing Cyclin D1 and CDK6
por: Zhong, Dan, et al.
Publicado: (2020)

Circulating microRNA-122a as a diagnostic marker for hepatocellular carcinoma
por: Luo, Jie, et al.
Publicado: (2013)

Circulating MicroRNA-122 for the Diagnosis of Hepatocellular Carcinoma: A Meta-Analysis
por: Zhao, Xiao-Fei, et al.
Publicado: (2020)

Farnesoid X receptor inhibits LNcaP cell proliferation via the upregulation of PTEN
por: LIU, JUN, et al.
Publicado: (2014)

Diagnostic Performance of microRNA-122 and microRNA-224 in Hepatitis C Virus-Induced Hepatocellular Carcinoma (HCC)
por: Shehab-Eldeen, Somaia, et al.
Publicado: (2019)

Circulating MicroRNA-21 and MicroRNA-122 as Prognostic Biomarkers in Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization
por: Pelizzaro, Filippo, et al.
Publicado: (2021)

microRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma
por: Burchard, Julja, et al.
Publicado: (2010)

MicroRNA-122 Triggers Mesenchymal-Epithelial Transition and Suppresses Hepatocellular Carcinoma Cell Motility and Invasion by Targeting RhoA
por: Wang, Sheng-Chun, et al.
Publicado: (2014)

The Farnesoid X Receptor: Good for BAD
por: Keely, Stephen J., et al.
Publicado: (2016)

The Predictive Efficacy of Serum Exosomal microRNA-122 and microRNA-148a for Hepatocellular Carcinoma Based on Smart Healthcare
por: Deng, Peng, et al.
Publicado: (2022)

MicroRNA-122 mimic/microRNA-221 inhibitor combination as a novel therapeutic tool against hepatocellular carcinoma
por: Hassan, Marwa, et al.
Publicado: (2022)

Farnesoid X receptor activation by bile acids suppresses lipid peroxidation and ferroptosis
por: Tschuck, Juliane, et al.
Publicado: (2023)

Farnesoid X receptor is inhibited after ileum transposition in diabetic rats: its hypoglycemic effect
por: Chen, Weijie, et al.
Publicado: (2023)

Norcholic Acid Promotes Tumor Progression and Immune Escape by Regulating Farnesoid X Receptor in Hepatocellular Carcinoma
por: Gong, Yihang, et al.
Publicado: (2021)

Farnesoid X receptor associates with β-catenin and inhibits its activity in hepatocellular carcinoma
por: Liu, Xijun, et al.
Publicado: (2015)

Liver-specific microRNA-122: Biogenesis and function
por: Jopling, Catherine
Publicado: (2012)

Farnesoid X receptor (FXR): Structures and ligands
por: Jiang, Longying, et al.
Publicado: (2021)

Irisin Is Controlled by Farnesoid X Receptor and Regulates Cholesterol Homeostasis
por: Li, Hong, et al.
Publicado: (2019)

Circulating microRNAs (miR‐16, miR‐22, miR‐122) expression and early diagnosis of hepatocellular carcinoma
por: Fang, Yujia, et al.
Publicado: (2022)

Prognostic value of serum microRNA-122 in hepatocellular carcinoma is dependent on coexisting clinical and laboratory factors
por: Franck, Martin, et al.
Publicado: (2020)

MicroRNA-122 affects cell aggressiveness and apoptosis by targeting PKM2 in human hepatocellular carcinoma
por: Xu, Qiuran, et al.
Publicado: (2021)

MicroRNA‐122 promotes apoptosis of keratinocytes in oral lichen planus through suppressing VDR expression
por: Ge, Xuejun, et al.
Publicado: (2021)

Diabetic Nephropathy Is Accelerated by Farnesoid X Receptor Deficiency and Inhibited by Farnesoid X Receptor Activation in a Type 1 Diabetes Model
por: Wang, Xiaoxin X., et al.
Publicado: (2010)

Sensitivity and specificity of microRNA‐122 for liver disease in dogs
por: Oosthuyzen, W., et al.
Publicado: (2018)

Roles of MicroRNA-122 in Cardiovascular Fibrosis and Related Diseases
por: Liu, Ying, et al.
Publicado: (2020)

Ratio of microRNA-122/155 in isoniazid-induced acute liver injury in mice
por: Song, Lei, et al.
Publicado: (2016)

MicroRNA-122 Regulation of HCV Infections: Insights from Studies of miR-122-Independent Replication
por: Panigrahi, Mamata, et al.
Publicado: (2022)

Molecular tuning of farnesoid X receptor partial agonism
por: Merk, Daniel, et al.
Publicado: (2019)

Microbiota-induced obesity requires farnesoid X receptor
por: Parséus, Ava, et al.
Publicado: (2017)

Role of Farnesoid X Receptor in the Pathogenesis of Respiratory Diseases
por: Wu, Jin-nan, et al.
Publicado: (2020)

The Farnesoid X Receptor as a Master Regulator of Hepatotoxicity
por: Rausch, Magdalena, et al.
Publicado: (2022)

Bile Acids Elevated in Chronic Periaortitis Could Activate Farnesoid-X-Receptor to Suppress IL-6 Production by Macrophages
por: Cao, Shan, et al.
Publicado: (2021)

MYC Promotes LDHA Expression through MicroRNA-122-5p to Potentiate Glycolysis in Hepatocellular Carcinoma
por: Wang, Xiaofei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1b3th5i639c8c99sasmgo0eeam